Biblio Discovery — Demo Discovery Service

12 hasil untuk "Yanlang He"

Menampilkan 1–12 · 0,31 detik · RSS

  1. Artikel Jurnal

    Case Report: Abruptio placentae and epileptic seizure after occurrence of perinatal hyperglycaemia in woman with gestational diabetes mellitus and hypertriglyceridemia-induced acute pancreatitis

    Yanlang He; Zhijie Huang; Changli Wei dkk.

    Frontiers in Endocrinology, Vol. 14 · 2023 · Inggris · DOAJ Scopus

    Hypertriglyceridemia-induced acute pancreatitis seldom occurs in the second trimester of pregnancy with gestational diabetes mellitus. For these patients, the existing knowledge on concomitant hyperglycemia is not sufficient. We report a case of abruptio placentae and epileptic seizure following…

  2. Artikel Jurnal

    Severe iron-deficiency anemia after short-term moderate consumption of green tea in woman: A rare case report

    Yanlang He; Jianyong Chen

    Heliyon, Vol. 10 No. 17 · 2024 · Inggris · DOAJ Scopus

    While the mechanisms by which tea consumption hinders iron absorption are well understood, tea-related anemia usually stems from prolonged and excessive intake, which obstructs iron absorption and depletes the body's iron reserves. Consequently, it is uncommon for hemoglobin levels to plummet by…

  3. Artikel Jurnal

    Super-refractory status epilepticus in a woman with Aeromonas caviae meningitis: a rare case report and review of the literature

    Yanlang He; Jia Liu; Sheng Wei dkk.

    Frontiers in Medicine, Vol. 11 · 2024 · Inggris · DOAJ Scopus

    Currently, there is a lack of knowledge regarding Aeromonas caviae meningitis. We report the first case of super-refractory status epilepticus (SRSE) in a woman with Aeromonas caviae meningitis. The case report demonstrates that this condition can lead to severe SRSE. Effective treatment for…

  4. Artikel Jurnal

    Comparative safety profile of levofloxacin versus moxifloxacin in first-line tuberculosis therapy: a pharmacovigilance study of the FAERS database

    Yanlang He; Lifen Liang; Sheng Wei

    Frontiers in Pharmacology, Vol. 16 · 2025 · Inggris · DOAJ Scopus

    ObjectiveThis study aimed to compare the safety profiles of two fluoroquinolone-containing regimens, HREL (isoniazid, rifampicin, ethambutol, levofloxacin) and HREM (isoniazid, rifampicin, ethambutol, moxifloxacin), in the treatment of drug-susceptible tuberculosis (DS-TB), focusing on adverse…

  5. Artikel Jurnal

    Giant intracranial Brucella abscess after head trauma: a Case Report of neurobrucellosis in an urban elderly male without exposure history

    Yanlang He; Lifen Liang; Sheng Wei

    Frontiers in Medicine, Vol. 12 · 2025 · Inggris · DOAJ Scopus

    Giant intracranial Brucella abscess is a severe and rare central nervous system infection whose pathogenesis remains incompletely understood. We detail the case of a 75-years-old urban male without Brucella exposure history who presented with fever and headache. Initial attribution of cephalgia to…

  6. Artikel Jurnal

    The NLRP3 inflammasome in metabolic dysfunction-associated steatotic liver disease: role and advances in therapeutic targeting

    Sheng Wei; Yanlang He; Chen Luo dkk.

    Frontiers in Immunology, Vol. 17 · 2026 · Inggris · DOAJ Scopus

    Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly termed non-alcoholic fatty liver disease (NAFLD), has become the most prevalent chronic liver disease worldwide. Its disease spectrum begins with simple steatosis, progresses through steatohepatitis (MASH, formerly NASH) and…

  7. Artikel Jurnal

    Will the introduction of β-lactamase inhibitors alter the adverse event profile of parent penicillins antibiotics? a pharmacovigilance study based on amoxicillin-clavulanate and ampicillin-sulbactam

    Yanlang He; Yunxia Liao; Guie Xiao dkk.

    Frontiers in Pharmacology, Vol. 17 · 2026 · Inggris · DOAJ Scopus

    ObjectiveThis study aimed to investigate whether the introduction of β-lactamase inhibitors (BLIs) alters the adverse event (AE) profiles of parent penicillin antibiotics, using real-world pharmacovigilance data.MethodsA disproportionality analysis was conducted using reports from the FDA Adverse…

  8. Artikel Jurnal

    Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives

    Yanlang He; Xiangping Xie; Shuangyan He dkk.

    Frontiers in Immunology, Vol. 17 · 2026 · Inggris · DOAJ Scopus

    Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains the leading cause of death from a single infectious agent worldwide, with 10.7 million new cases and 1.23 million deaths reported globally in 2024. Although conventional chemotherapy cures most drug-susceptible TB, the rising…

  9. Artikel Jurnal

    Which fluoroquinolone is safer when combined with bedaquiline for tuberculosis treatment: evidence from FDA Adverse Event Reporting System database from 2013 to 2024

    Sheng Wei; Changping He; Xiangping Xie dkk.

    Frontiers in Pharmacology, Vol. 15 · 2024 · Inggris · DOAJ Scopus

    ObjectiveTo investigate which fluoroquinolone is safer when combined with bedaquiline for tuberculosis treatment by using the FDA Adverse Event Reporting System (FAERS) database.MethodsWe selected data from the first quarter (Q1) of 2013 to the second quarter (Q4) of 2024 from the FDA FAERS…

  10. Artikel Jurnal

    Association of the atherogenic index of plasma and its integrative novel adiposity-based composites with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome: novel adiposity-derived AIP indices provide modest incremental prognostic information

    Sheng Wei; Jiajun Qiu; Yong Liu dkk.

    Cardiovascular Diabetology, Vol. 25 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Background Cardiovascular-kidney-metabolic (CKM) syndrome is recognized as a progressive pathophysiological continuum linking metabolic dysfunction, dysfunctional adiposity, chronic kidney disease, and cardiovascular injury. The atherogenic index of plasma (AIP) reflects lipid-related…